Ligands for peroxisome proliferator-activated receptor inhibit monocyte CCR2 expression stimulated by plasma lipoproteins

Trends in Cardiovascular Medicine

Volumn 10, Issue 5, 2000, Pages 209-216

  Han, Ki Hoon ^a   Quehenberger, Oswald ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; LIGAND; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE;

ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHEMOTAXIS; GENE EXPRESSION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CHEMOKINE CCL2; HUMANS; LIGANDS; LIPOPROTEINS, LDL; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0034466372     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00076-1     Document Type: Review

References (40)

1. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
2. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
3. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
4. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein
5. Biology of chemokine and classical chemoattractant receptors; differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells
6. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails
7. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
8. The role of the monocyte in atherogenesis; I. Transition of blood-borne monocytes into foam cells in fatty lesions
9. Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta
10. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
11. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
12. Monocyte chemoattractant protein-1
13. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor γ
14. Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling
15. Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia; differential effects of plasma lipoproteins on monocyte function
16. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL
17. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
18. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
19. Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats
20. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
21. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
22. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
23. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1α receptor, confers chemokine selectivity
24. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes
25. International union of pharmacology. XXII. Nomenclature for chemokine receptors
26. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
27. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function
28. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE
29. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium
30. Traffic signals for lymphocyte recirculation and leukocyte emigration; the multistep paradigm
31. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
32. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
33. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines
34. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
35. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
36. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
37. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia
38. The PPARs; from orphan receptors to drug discovery
39. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
40. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates